Stunning cancer advances: Scientists report zero relapses in major trial

Jimmy Hinton of America Out Loud Talk Radio delivers a powerful and hopeful episode spotlighting groundbreaking advances in colorectal cancer treatment, centered on the Neoprism-CRC clinical trial. The study, led by University College London and UCL Hospital, demonstrates that a short course of pre-surgical immunotherapy with pembrolizumab—replacing traditional post-surgery chemotherapy—led to zero cancer relapses in 32 patients with stage 2 or 3 bowel cancer after 33 months of follow-up. This is a dramatic improvement over the standard 25% relapse rate with chemotherapy. Hinton shares personal stories of loss and resilience, emphasizing the emotional toll of cancer while celebrating the scientific breakthroughs. He also highlights a complementary study in which engineered bacteria are trained to consume tumors from within, using precision gene editing and quorum sensing to target cancerous tissue without harming healthy cells. The episode blends heartfelt storytelling with urgent public health messaging, urging listeners to prioritize screenings and adopt healthier lifestyles, particularly through clean eating and avoiding processed foods. Hinton critiques the current food system and praises advocates like RFK Jr. for raising awareness about environmental and dietary contributors to rising cancer rates, especially among younger populations.